Recent studies have shown that the high expression of RAG1 is a potential driver of oncogenesis in B-cell ALL, and the aberrant activity of RAG1/2 is associated with the promotion of lymphocytic malignancies due to chromosomal translocations and DNA deletions in cancer genes [25,26]. Here, RAG1 is linked to cancer.